Literature DB >> 12153840

Gender differences in the symptoms of major depression in opposite-sex dizygotic twin pairs.

Amir A Khan1, Charles O Gardner, Carol A Prescott, Kenneth S Kendler.   

Abstract

OBJECTIVE: Gender differences in the symptoms of major depression have received limited research attention. The aim of this study was to explore these differences in male-female twin pairs.
METHOD: Telephone interviews were conducted to determine the lifetime history of major depression in 1,404 complete pairs of opposite-sex dizygotic twins identified through a population-based registry. From these, the authors selected 201 pairs in which both twins fulfilled the DSM-III-R criteria for lifetime major depression. Dichotomous symptom variables were analyzed by using McNemar's chi-square. For continuous variables, conditional logistic regression was used.
RESULTS: Female twins reported experiencing significantly more fatigue, hypersomnia, and psychomotor retardation during the most severe major depressive episode, whereas male twins reported more insomnia and agitation.
CONCLUSIONS: In this group of matched twins, gender differences in the symptoms of major depression were seen in the areas of sleep, psychomotor changes, and fatigue. Gender significantly modifies some clinical features of major depression.

Entities:  

Mesh:

Year:  2002        PMID: 12153840     DOI: 10.1176/appi.ajp.159.8.1427

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  23 in total

1.  Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.

Authors:  Michael E Thase; Harald Murck; Anke Post
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Utility of self-reported sleep disturbances as a marker for major depressive disorder (MDD): findings from the World Mental Health Japan Survey 2002-2006.

Authors:  Shuntaro Ando; Norito Kawakami
Journal:  Psychiatry Res       Date:  2012-02-28       Impact factor: 3.222

3.  Robust symptom networks in recurrent major depression across different levels of genetic and environmental risk.

Authors:  H M van Loo; C D Van Borkulo; R E Peterson; E I Fried; S H Aggen; D Borsboom; K S Kendler
Journal:  J Affect Disord       Date:  2017-10-29       Impact factor: 4.839

4.  Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

Authors:  Karen K Miller; Roy H Perlis; George I Papakostas; David Mischoulon; Dan V Losifescu; Danielle J Brick; Maurizio Fava
Journal:  CNS Spectr       Date:  2009-12       Impact factor: 3.790

5.  Test-retest & familial concordance of MDD symptoms.

Authors:  Ariela J E Kaiser; Carter J Funkhouser; Vijay A Mittal; Sebastian Walther; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2020-07-20       Impact factor: 3.222

6.  Sleepless from the Get Go: Sleep Problems Prior to Initiating Cancer Treatment.

Authors:  Eric S Zhou; Karen Clark; Christopher J Recklitis; Richard Obenchain; Matthew Loscalzo
Journal:  Int J Behav Med       Date:  2018-10

7.  Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria.

Authors:  V Lux; K S Kendler
Journal:  Psychol Med       Date:  2010-01-11       Impact factor: 7.723

8.  Insomnia symptoms, sleep duration, and disability pensions: a prospective study of Swedish workers.

Authors:  Catarina Canivet; Carin Staland-Nyman; Sara I Lindeberg; Robert Karasek; Mahnaz Moghaddassi; Per-Olof Östergren
Journal:  Int J Behav Med       Date:  2014-04

9.  TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes.

Authors:  Yuhua Sun; Bojana Zupan; Bruce M Raaka; Miklos Toth; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853

10.  Epidemiology and symptomatology of depression in Sri Lanka: a cross-sectional population-based survey in Colombo District.

Authors:  Harriet A Ball; Sisira H Siribaddana; Yulia Kovas; Nick Glozier; Peter McGuffin; Athula Sumathipala; Matthew Hotopf
Journal:  J Affect Disord       Date:  2009-09-16       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.